Insight Report 5 minutes PremiumCoronavirus Insights: US Drugstores Step Up; Potential Drug Shortages Could Be a Long-Term Concern Coresight Research March 23, 2020 What's InsideWith the coronavirus continuing to spread globally, we consider its impact in the US drugstore sector. CVS, Rite Aid and Walgreens are adapting their services in response to the shifting landscape. We discuss the initiatives that these major drugstore chains in the US are rolling out to support consumers during the outbreak, including waiving fees and offering innovative, minimal-contact testing services. We also consider the potential challenge of drug shortages in the US over the longer term, due to the nation’s reliance on China in the medicine manufacturing supply chain. Click here to view Coresight Research’s ongoing coverage of the coronavirus outbreak. Already a subscriber? Log in You are currently viewing a preview of this report. Please select an access option to view the full report. Hide Options - Show Options + Get unlimited access to all our research with one of our subscription plans. View Subscription Plans or Contact us to purchase this report. Contact us ✕ This document was generated for Other research you may be interested in: Innovator Profile: Dragonfruit AI Transforms Video Surveillance Data into Essential InsightsRobotics in Retail—Part 2: Service Bots Automate and Upgrade the In-Store ExperienceUS Store Tracker Extra, April 2023: Bed Bath & Beyond Pushes Total Closed Space to 52 Million Square FeetUS Drugstores and Pharmacies: Real Estate Insights—Closures Lead to 8 Million Square Feet of Shuttered Retail Space in 2024
